Works matching DE "AIDS vaccination research"


Results: 35
    1
    2
    3

    Back to basics.

    Published in:
    Nature Medicine, 2009, v. 15, n. 8, p. 821, doi. 10.1038/nm0809-821
    Publication type:
    Article
    4
    5
    6

    Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site.

    Published in:
    PLoS Pathogens, 2015, v. 11, n. 5, p. 1, doi. 10.1371/journal.ppat.1004932
    By:
    • Crooks, Ema T.;
    • Tong, Tommy;
    • Chakrabarti, Bimal;
    • Narayan, Kristin;
    • Georgiev, Ivelin S.;
    • Menis, Sergey;
    • Huang, Xiaoxing;
    • Kulp, Daniel;
    • Osawa, Keiko;
    • Muranaka, Janelle;
    • Stewart-Jones, Guillaume;
    • Destefano, Joanne;
    • O’Dell, Sijy;
    • LaBranche, Celia;
    • Robinson, James E.;
    • Montefiori, David C.;
    • McKee, Krisha;
    • Du, Sean X.;
    • Doria-Rose, Nicole;
    • Kwong, Peter D.
    Publication type:
    Article
    7
    8
    9

    Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 6, p. 1833, doi. 10.1093/jac/dkv046
    By:
    • Mothe, Beatriz;
    • Climent, Nuria;
    • Plana, Montserrat;
    • Rosàs, Miriam;
    • Jiménez, José Luis;
    • Muñoz-Fernández, María Ángeles;
    • Puertas, María C.;
    • Carrillo, Jorge;
    • Gonzalez, Nuria;
    • León, Agathe;
    • Pich, Judit;
    • Arnaiz, Joan Albert;
    • Gatell, Jose M.;
    • Clotet, Bonaventura;
    • Blanco, Julià;
    • Alcamí, José;
    • Martinez-Picado, Javier;
    • Alvarez-Fernández, Carmen;
    • Sánchez-Palomino, Sonsoles;
    • Guardo, Alberto C.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15

    News in brief.

    Published in:
    Nature Reviews Drug Discovery, 2006, v. 5, n. 9, p. 710, doi. 10.1038/nrd2150
    Publication type:
    Article
    16
    17
    18
    19
    20

    HIV/AIDS Vaccines: 2007.

    Published in:
    Clinical Pharmacology & Therapeutics, 2007, v. 82, n. 6, p. 686, doi. 10.1038/sj.clpt.6100408
    By:
    • Robinson, H. L.
    Publication type:
    Article
    21

    Immune activation alters cellular and humoral responses to yellow fever 17D vaccine.

    Published in:
    Journal of Clinical Investigation, 2014, v. 124, n. 7, p. 3147, doi. 10.1172/JCI75429
    By:
    • Muyanja, Enoch;
    • Ssemaganda, Aloysius;
    • Ngauv, Pearline;
    • Cubas, Rafael;
    • Perrin, Helene;
    • Srinivasan, Divya;
    • Canderan, Glenda;
    • Lawson, Benton;
    • Kopycinski, Jakub;
    • Graham, Amanda S.;
    • Rowe, Dawne K.;
    • Smith, Michaela J.;
    • Isern, Sharon;
    • Michael, Scott;
    • Silvestri, Guido;
    • Vanderford, Thomas H.;
    • Castro, Erika;
    • Pantaleo, Giuseppe;
    • Singer, Joel;
    • Gillmour, Jill
    Publication type:
    Article
    22
    23
    24
    25
    26

    The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen.

    Published in:
    Science Translational Medicine, 2018, v. 10, n. 448, p. 1, doi. 10.1126/scitranslmed.aat0381
    By:
    • Havenar-Daughton, Colin;
    • Sarkar, Anita;
    • Kulp, Daniel W.;
    • Toy, Laura;
    • Hu, Xiaozhen;
    • Deresa, Isaiah;
    • Kalyuzhniy, Oleksandr;
    • Kaushik, Kirti;
    • Upadhyay, Amit A.;
    • Menis, Sergey;
    • Landais, Elise;
    • Cao, Liwei;
    • Diedrich, Jolene K.;
    • Kumar, Sonu;
    • Schiffner, Torben;
    • Reiss, Samantha M.;
    • Seumois, Grégory;
    • Yates, John R.;
    • Paulson, James C.;
    • Bosinger, Steven E.
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33

    HIV: Design by trial.

    Published in:
    Nature, 2012, v. 490, n. 7420, p. 350, doi. 10.1038/490350a
    By:
    • Glidden, David V.
    Publication type:
    Article
    34
    35